期刊文献+

他克莫司联合小剂量泼尼松治疗儿童特发性膜性肾病致酮症酸中毒 被引量:3

Ketoacidosis in a boy with idiopathic membranous nephropathy during combined therapy with tacrolimus and low-dose prednisone
原文传递
导出
摘要 1例8岁男性患儿因特发性膜性肾病应用他克莫司(1.25 mg,1次/12 h)联合泼尼松(12.5 mg,隔日1次)口服治疗。5周后,患儿相继出现多饮、多尿、呕吐、嗜睡、脱水征。实验室检查:空腹葡萄糖22.4 mmol/L,动脉血酸碱度7.24,标准碳酸氢盐12 mmol/L,尿酮体(+++)。诊断为酮症酸中毒。停用他克莫司,给予静脉补液(2125 ml/d)及重组人胰岛素2.5 U/h持续静脉输注。10 h后血酸碱度7.40,空腹葡萄糖8.5 mmol/L,连续2次检测尿酮体均为阴性,改为三餐前皮下注射重组人胰岛素6.25 U。3周后,患儿空腹葡萄糖5.9 mmol/L。 An 8-year-old boy received concomitant treatment with tacrolimus 1. 25 mg every 12 hours and prednisone 12. 5 mg once every other day for idiopathic membranous nephropathy. Five weeks later,the boy developed polydipsia,polyuria,vomiting,somnolence,and dehydration. Laboratory tests showed the following values:fasting plasma glucose 22. 4 mmol/L,blood pH 7. 24,standard bicarbonate 12 mmol/L,and urine ketone bodies( +++). The patient was diagnosed with ketoacidosis. Tacrolimus was stopped and he was treated with fluid supplementation 2 125 ml/d and continuous IV infusion of recombinant human insulin 2. 5 U/h. After 10 hours,laboratory results indicated that blood pH was 7. 40,fasting plasma glucose was 8. 5 mmol/L,and detection of urine ketone was negative for two times in a row. Then,his treatment was switched to subcutaneous injection of recombinant human insulin 6. 25 U before three meals. After 3 weeks,the fasting plasma glucose was 5. 9 mmol/L.
出处 《药物不良反应杂志》 CSCD 2014年第5期304-305,共2页 Adverse Drug Reactions Journal
关键词 他克莫司 泼尼松 酮症酸中毒 Tacrolimus Prednisone Ketoacidosis
  • 相关文献

参考文献7

  • 1Filler G, Neuschulz I, Vollmer I, et al. Tacrolimus reversibly reduces insulin secretion in paediatrlc renal transplant recipients [J]. Nephrol Dial Transplant, 2000, 15(6) :867-871.
  • 2Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis [ J ]. Am J Transplant, 2004, 4 ( 4 ) : 583-595.
  • 3Vineenti F, Friman S, Seheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with eyelosporine versus taerolimus [ J ]. Am J Transplant, 2007, 7(6) :1506-1514.
  • 4Duijnhoven EM, Boots JM, Christiaans MH, et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study [ J ]. J Am Soc Nephml, 2001, 12(3) :583-588.
  • 5王振,高江平,罗芸,卢锦山,敖建华,肖序仁,洪宝发,石炳毅,薛毅珑.不同浓度他克莫司在体外对胰岛的毒性作用及致糖尿病作用的临床研究[J].中华器官移植杂志,2006,27(11):681-684. 被引量:15
  • 6Chen M, Li H, Li XY, et al. acrolimus combined with corti- costeroids in treatment of nephrotic idiopathic membranous nephropathy:a multicenter randomized controlled trial [ J ]. Am J Med Sci, 2010, 339(3) : 233-238.
  • 7Li X, Lv R, He Q, et al. Early initiation of tacrolimus or cyclop- hosphamide therapy for idiopathic membranous nephropathy with severe proteinuria[ J]. J Nephrol, 2008, 21 (4) : 584-591.

二级参考文献11

  • 1Meredith M, Li G, Metz SA. Inhibition of calcium-induced insulin secretion from intact HIT-T15 or INS-1 beta cells by GTP depletion. Biochem Pharmacol, 1997,53 : 1873-1882.
  • 2Ishizuka J, Gugliuzza KK, Wassmuth Z, et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation, 1993,56 : 1486-1490.
  • 3Gray DW, McShane P, Grant A, et al. A method for isolation of islets of Langerhans from the human pancreas. Diabetes, 1984,33 : 1055-1061.
  • 4Warnock GL, Ellis D, Rajotte RV, et al. Studies of the isolation and viability of human islets of Langerhans. Transplantation,1988,45 : 957-963.
  • 5Latif ZA, Noel J,Alejandro R. et al. A simple method of staining fresh and cultured islets. Transplantation, 1988,45 : 827-830.
  • 6Aamerican Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2005,28 : 37-42.
  • 7Lawrence MC, Bhatt HS, Watterson JM, et al. Regulation of insulin gene transcription by a Ca^2+ -responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol,2001, 15 : 1758-1767.
  • 8Young MC, Kyong S, Jongwon HA, et al. High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American diabetes association criteria. Diabetes Care,2003,26: 1123-1128.
  • 9Van Hooff,Johannes P,Christiaans MH. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant,2004,19 : 8-12.
  • 10Shapiro AM,Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med,2000,343 : 230-238.

共引文献14

同被引文献14

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部